Millennium gains broad access to human antibody technology through collaboration with Abgenix.(Brief Article)(Statistical Data Included)

From: BIOTECH Patent News | Date: March 1, 2000 | Copyright information

Millennium Pharmaceuticals, Inc. (Cambridge, MA; 617-679-7000) announced that it has signed an agreement for an expanded relationship with Abgenix, Inc. (Fremont, CA) through which it will gain extensive access to Abgenix's XenoMouse technology for the creation of fully human antibodies. Abgenix will receive an undisclosed upfront payment and potential future payments that could reach $100 million plus royalties on product sales.

Under this new agreement, Millennium wi...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Millennium, Abgenix In Antibody Alliance.
Chemical Market Reporter ; MILLENNIUM PHARMACEUTICALS Inc. iS expanding its relationship with Abgenix Inc. to include extensive access to Abgenix's XenoMouse technology for the creation of fully human antibodies. Abgenix will receive an undisclosed upfront payment and potential future payments that could reach $100 million
Jumping on the millennium bandwagon
Chicago Sun-Times ; "Millennium," the album by the Backstreet Boys that has been breaking sales records, oddly enough has nothing to do with the Year 2000 and everything to do with May 1999. It was released that month after a marketing campaign featuring a daily countdown: "30 Days to the Millennium," "29 . . "28 . .
Millennium restates earnings after accounting 'errors'.(United States/Americas)(Millennium Chemicals)
Chemical Week ; ... million; and reduce shareholders equity by more than $400 million. Millennium's share price was not significantly affected by the news. While rarely a positive sign, the announced restatements should not reflect negatively on Millennium's shares, says Donald Carson ...
Millennium's new game plan
Pharmaceutical Executive ; ... Millennium's products will perform in the market is still uncertain. In July, Forbes.com reported in "Millennium: Now, the Bad News" that "the revenue picture for Integrilin will be weaker than the company projected. The company's original expectation for 2003 ...
Analysts Expect a Strong Future for Millennium While Cutting Q3 Estimates.
Chemical Market Reporter ; DESPITE THE COLLAPSE of Millennium Chemicals' share price over the past month, analysts remain confident that [TiO.sub.2] is a differentiated and solid business and that an Equistar Chemicals LP disposal is in the near-term cards for the company. Although analysts are trimming their third quarter
Millennium flashback... or fast forward?
The Milwaukee Journal Sentinel ; ... for much other than the routine New Year's Eve parties, complete with that old Scottish song with lyrics that, like millennium observances, make no sense at all. Howard Kleinberg, a former editor of the Miami News, is a columnist for Cox Newspapers.
Lyondell takeover of Millennium delayed.(United States/Americas)
Chemical Week ; Lyondell Chemical and Millennium Chemicals say they have delayed the expected completion of Lyondell's takeover of Millennium until the fourth quarter following Millennium's recent announcement that it will restate earnings to correct certain tax errors (CW, April 7/14, p. 8). The companies had
`MILLENNIUM' CROSSES THE LINE IN GRUESOMENESS.(Television)(Review)
Seattle Post-Intelligencer (Seattle, WA) ; ... approach of the millennium seems to coincide with the demise of humanity, a fact all too evident in the evening news. However, there is also good news, for a force is at work to begin to reverse the horror of the inevitable. May it not be too late.'' Sheesh ...
Millennium replaces CEO as losses deepen. (top of the week).
Chemical Week ; Millennium Chemicals chairman and CEO William M. Landuyt resigned last month as the company warned of a deeper second-quarter net loss, suspended its dividend, and announced plans to slash 175 jobs, 4.6% of its total. Millennium has named Robert E. Lee, executive v.p. and board member, as CEO; and
Millennium Parties With Arca: Done Deal, But Can Crossing System Make a Comeback?
Traders ; The beleaguered Millennium crossing system may get a shot in the arm under a deal that allows it to expose its orders on the Archipelago Exchange. The deal, signed with Archipelago by NYFIX, Millennium's owner, breaks new ground. Since its launch nearly four years ago, NYFIX has operated Millennium